Dr. Moawad is a neurologist and expert in brain health. She regularly writes and edits health content for medical books and publications. Supplements containing protein are recommended for people who ...
Nutrabolt, an energy drink and supplements company, has picked investment banks to lead an initial public offering that ...
Glucagon-like peptide-1 receptor agonists (GLP-1s) have become well known for their significant role as an aid in weight loss ...
Everyday Health on MSN
The 15 best protein powders to kick-start your health journey, recommended by RDs
Looking for the best protein powder? Our guide highlights the top picks for weight loss, women, budget, and more, tested and ...
A new systematic review and meta-analysis suggests that increasing (and maintaining) step counts to around 8,500 steps a day is helpful for maintaining significant weight loss long term. Experts say ...
Share on Pinterest A new experimental weight loss drug from Eli Lilly shows dramatic results that rival current GLP-1 drugs and bariatric surgery. Image Credit: Scott Olson/Getty Images Eli Lilly’s ...
New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone.
For decades, people have been told that their weight problems can be solved by math: Calories in, calories out. If weight were a simple math equation, more people would likely be the weight they ...
Eli Lilly on May 21 said its experimental weight-loss shot retatrutide delivered dramatic weight loss in a late-stage study of people with obesity. Lilly said people on the next-generation weight loss ...
Retatrutide, a powerful experimental weight-loss drug that mimics three different hormones the body produces after eating, helped people lose 70 pounds on average, or 28% of their body weight, ...
Eli Lilly said its next-generation drug cleared a crucial late-stage trial in patients with obesity, delivering significant weight loss across doses. The results bring Lilly one step closer to filing ...
People who got the injection, retatrutide, lost 28 percent of their body weight on average after 80 weeks, Eli Lilly said. By Gina Kolata and Rebecca Robbins An experimental shot helped participants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results